Accelerated apoA-I catabolism with decreased apoA-II production patients with end-stage renal disease: Stable isotope studies

被引：0
|
作者：
Ikewaki, K
Schaefer, JR
Okubo, K
Schwarz, S
Kronenberg, F
Schweer, H
Koenig, P
Hosoya, T
Mochizuki, S
Dieplinger, H
机构：
[1] Jikei Univ, Div Cardiol, Sch Med, Tokyo, Japan
[2] Univ Marburg, Dept Internal Med Cardiol, Marburg, Germany
[3] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan
[4] Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria
[5] Univ Marburg, Childrens Hosp, Marburg, Germany
[6] Univ Innsbruck, Dept Clin Nephrol, A-6020 Innsbruck, Austria
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
622
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [41] Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study
    Schwade, Mark J.
    Tien, Lillie
    Waller, Jennifer L.
    Davis, Loretta S.
    Baer, Stephanie L.
    Mohammed, Azeem
    Young, Lufei
    Kheda, Mufaddal F.
    Bollag, Wendy B.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (01): : 24 - 33
  • [42] RELIABILITY OF THE SPANISH VERSION OF THE NOTTINGHAM HEALTH PROFILE IN PATIENTS WITH STABLE END-STAGE RENAL-DISEASE
    BADIA, X
    ALONSO, J
    BROSA, M
    LOCK, P
    SOCIAL SCIENCE & MEDICINE, 1994, 38 (01) : 153 - 158
  • [43] Profiles of B-cell subsets in immunologically stable renal allograft recipients and end-stage renal disease patients
    Zhuang, Quan
    Li, Hao
    Yu, Meng
    Peng, Bo
    Liu, Shu
    Luo, Ming
    Stefano, George B.
    Kream, Richard M.
    Ming, Yingzi
    TRANSPLANT IMMUNOLOGY, 2020, 58
  • [44] Evaluation of Human Leukocyte Antigen Class I and Class II in End-Stage Renal Disease Occurrence in Indonesian Transplantation Patients
    Susianti, Hani
    Djatmiko, Dwi Priyadi
    Widana, I. Komang Adi
    Tandio, Deasy Ayuningtyas
    Sutrisnani, Catur Suci
    Wahono, Singgih Pudjo
    Puspitawati, Ira
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2021, 2021
  • [45] In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide
    Vaziri, Nosratola D.
    Moradi, Hamid
    Pahl, Madeleine V.
    Fogelman, Alan M.
    Navab, Mohamad
    KIDNEY INTERNATIONAL, 2009, 76 (04) : 437 - 444
  • [46] Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies
    Cherng, Yih-Giun
    Lin, Chao-Shun
    Shih, Chun-Chuan
    Hsu, Yung-Ho
    Yeh, Chun-Chieh
    Hu, Chaur-Jong
    Chen, Ta-Liang
    Liao, Chien-Chang
    PLOS ONE, 2018, 13 (01):
  • [47] A confirmatory factor analysis of the beck depression inventory-II in end-stage renal disease patients
    Chilcot, Joseph
    Norton, Sam
    Wellsted, David
    Almond, Mike
    Davenport, Andrew
    Farrington, Ken
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2011, 71 (03) : 148 - 153
  • [48] TUNNELED DIALYSIS CATHETER INFECTION AND TROPONINE-I LEVELS IN END-STAGE RENAL DISEASE PATIENTS
    Gharaibeh, K.
    Guild, C. S.
    Hamrahian, S. M.
    Lengvarszky, Z.
    Csongradi, E.
    Fulop, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 444 - 444
  • [49] "Should I go on dialysis, Doc?" Initiating dialysis in elderly patients with end-stage renal disease
    Seccareccia, Dori
    Downar, James
    CANADIAN FAMILY PHYSICIAN, 2012, 58 (12) : 1353 - 1356
  • [50] Hyperuricemia is associated with decreased renal function and occurrence of end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study
    Hyeok Chan Kwon
    Sung Soo Ahn
    Byung-Woo Yoo
    Juyoung Yoo
    Seung Min Jung
    Jason Jungsik Song
    Yong-Beom Park
    Sang-Won Lee
    Rheumatology International, 2020, 40 : 1089 - 1099
12345